CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Gentile Kimberly SVP, Clinical Operations | Grant or award · Stock Options (Right to buy) | +1,000 | 1,000 | ||
| 2026-04-28 | Antonijevic Irina Director | Grant or award · Stock Options (Right to buy) | +68,693 | 68,693 | ||
| 2026-04-28 | Mehta Kishan Director | Grant or award · Stock Options (Right to buy) | +68,693 | 68,693 | ||
| 2026-04-28 | Heffernan Michael Thomas Director | Grant or award · Stock Options (Right to buy) | +68,693 | 68,693 | ||
| 2026-04-28 | Bailey Gregory Director | Grant or award · Stock Options (Right to buy) | +68,693 | 68,693 | ||
| 2026-04-28 | HUGIN ROBERT J Director | Grant or award · Stock Options (Right to buy) | +68,693 | 68,693 | ||
| 2026-04-28 | GREGORY JULIA P Director | Grant or award · Stock Options (Right to buy) | +68,693 | 68,693 | ||
| 2026-04-28 | CHILDS JOHN W Director | Grant or award · Stock Options (Right to buy) | +68,693 | 68,693 | ||
| 2026-03-17 | Mehta Kishan Director | Gift | −17,342 | 5,320 | ||
| 2026-03-17 | Mehta Kishan Director | Gift | +17,342 | 17,342 | ||
| 2026-02-27 | Buten Matthew Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +175,000 | 175,000 | ||
| 2026-02-27 | Clark George C. VP, Chief Accounting Officer | Grant or award · Stock Options (Right to buy) | +50,000 | 50,000 | ||
| 2026-02-27 | Car Bruce Chief Scientific Officer | Grant or award · Stock Options (Right to buy) | +175,000 | 175,000 | ||
| 2026-02-27 | Coric Vlad Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +550,000 | 550,000 | ||
| 2026-02-27 | Gentile Kimberly SVP, Clinical Operations | Grant or award · Stock Options (Right to buy) | +175,000 | 175,000 | ||
| 2026-01-05 | Buten Matthew Chief Financial Officer | Option exercise | +4,250 | 198,246 | ||
| 2026-01-05 | Buten Matthew Chief Financial Officer | Shares withheld for taxes | −2,594 | $9.93 | $26K | 195,652 |
| 2026-01-05 | Buten Matthew Chief Financial Officer | Option exercise · Restricted Share Unit Award | −4,250 | 8,500 | ||
| 2026-01-05 | Clark George C. VP, Chief Accounting Officer | Option exercise | +2,500 | 68,095 | ||
| 2026-01-05 | Clark George C. VP, Chief Accounting Officer | Shares withheld for taxes | −1,117 | $9.93 | $11K | 66,978 |
Page 1 of 18 · 355 trades